Teleflex Incorporated logo

Teleflex Incorporated (TFX)

Market Closed
3 Jun, 20:00
NYSE NYSE
$
128. 56
+3.32
+2.65%
$
5.65B Market Cap
- P/E Ratio
0.54% Div Yield
558,709 Volume
- Eps
$ 125.24
Previous Close
Add Transaction
Day Range
125.91 129.57
Year Range
100.18 139.67
Want to track TFX and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Here's What Key Metrics Tell Us About Teleflex (TFX) Q1 Earnings

Here's What Key Metrics Tell Us About Teleflex (TFX) Q1 Earnings

While the top- and bottom-line numbers for Teleflex (TFX) give a sense of how the business performed in the quarter ended March 2025, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.

Zacks | 1 year ago
Teleflex (TFX) Tops Q1 Earnings and Revenue Estimates

Teleflex (TFX) Tops Q1 Earnings and Revenue Estimates

Teleflex (TFX) came out with quarterly earnings of $2.91 per share, beating the Zacks Consensus Estimate of $2.88 per share. This compares to earnings of $3.21 per share a year ago.

Zacks | 1 year ago
Earnings Preview: Teleflex (TFX) Q1 Earnings Expected to Decline

Earnings Preview: Teleflex (TFX) Q1 Earnings Expected to Decline

Teleflex (TFX) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Zacks | 1 year ago
Teleflex Announces Split Into 2 Public Companies

Teleflex Announces Split Into 2 Public Companies

Teleflex's (TFX 2.89%) fourth-quarter 2024 earnings conference call, held on February 27, 2025, revealed significant strategic shifts for the medical device company. In a transformative announcement, Teleflex outlined plans to acquire the Vascular Intervention business from Biotronik and separate into two publicly traded companies.

Fool | 1 year ago
Teleflex's Bold Transformation: Why I'm Skeptical On Value Creation

Teleflex's Bold Transformation: Why I'm Skeptical On Value Creation

Teleflex's management announced a significant acquisition and business split, but the market reacted negatively, dropping the shares over 20%. Fourth quarter earnings and 2025 guidance show weak revenue growth and margin leverage, with potential risks from tariffs and poor execution in key areas. The acquisition of BIOTRONIK's vascular intervention business is risky; it expands Teleflex's vascular intervention business, but the end markets aren't growing that fast and the company is a smaller player.

Seekingalpha | 1 year ago
Teleflex Stock Rises on Q4 Earnings Beat, Gross Margin Crashes

Teleflex Stock Rises on Q4 Earnings Beat, Gross Margin Crashes

TFX benefits from a diversified product portfolio in the fourth quarter of 2024, with strength in the Surgical and Interventional segments.

Zacks | 1 year ago
Teleflex Incorporated (TFX) Q4 2024 Earnings Call Transcript

Teleflex Incorporated (TFX) Q4 2024 Earnings Call Transcript

Teleflex Incorporated (NYSE:TFX ) Q4 2024 Earnings Conference Call February 27, 2025 8:00 AM ET Company Participants Lawrence Keusch - VP-IR & Strategy Development Liam Kelly - Chairman, President & CEO Thomas Powell - EVP & CFO John Deren - Corporate VP and Chief Accounting Officer Conference Call Participants Patrick Wood - Morgan Stanley Matthew O'Brien - Piper Sandler Jayson Bedford - Raymond James Shagun Singh - RBC Larry Biegelsen - Wells Fargo Anthony Petrone - Mizuho Group Richard Newitter - Truist Securities Craig Bijou - Bank of America Michael Polark - Wolfe Research Mike Matson - Needham Operator Good morning, ladies and gentlemen, and welcome to the Teleflex Fourth Quarter 2024 Earnings Conference Call. At this time all participants have been placed in a listen-only mode.

Seekingalpha | 1 year ago
Teleflex Hits 52-Week Low On Plan To Split Into Two Companies, Reports Mixed Q4 Earnings

Teleflex Hits 52-Week Low On Plan To Split Into Two Companies, Reports Mixed Q4 Earnings

On Thursday, Teleflex Incorporated TFX will pursue a plan to separate into two new, independent, publicly traded companies:

Benzinga | 1 year ago
Compared to Estimates, Teleflex (TFX) Q4 Earnings: A Look at Key Metrics

Compared to Estimates, Teleflex (TFX) Q4 Earnings: A Look at Key Metrics

Although the revenue and EPS for Teleflex (TFX) give a sense of how its business performed in the quarter ended December 2024, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.

Zacks | 1 year ago
Teleflex (TFX) Surpasses Q4 Earnings Estimates

Teleflex (TFX) Surpasses Q4 Earnings Estimates

Teleflex (TFX) came out with quarterly earnings of $3.89 per share, beating the Zacks Consensus Estimate of $3.86 per share. This compares to earnings of $3.38 per share a year ago.

Zacks | 1 year ago
Medical device maker Teleflex to split into two

Medical device maker Teleflex to split into two

Teleflex said on Thursday it would split into two by spinning off its business that makes devices for the urology, and acute care markets as well as its contract manufacturing unit.

Reuters | 1 year ago
Insights Into Teleflex (TFX) Q4: Wall Street Projections for Key Metrics

Insights Into Teleflex (TFX) Q4: Wall Street Projections for Key Metrics

Get a deeper insight into the potential performance of Teleflex (TFX) for the quarter ended December 2024 by going beyond Wall Street's top -and-bottom-line estimates and examining the estimates for some of its key metrics.

Zacks | 1 year ago
Loading...
Load More